Wolff–Parkinson–White syndrome: Difference between revisions
Ostermayer (talk | contribs) |
|||
| Line 12: | Line 12: | ||
*Accessory pathway used for anterograde conduction | *Accessory pathway used for anterograde conduction | ||
*QRS wide, delta wave present | *QRS wide, delta wave present | ||
==Atrial Fibrillation and Flutter== | |||
*[[Atrial fibrillation]] in up to 20% of pts with WPW | |||
*[[Atrial flutter]] in ~7% | |||
*Treatment with AV nodal blocking agents (adenosine, BBs, CCBs, amiodarone) may incite [[ventricular fibrillation]] or [[ventricular tachycardia]] | |||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 17:35, 2 May 2016
Background
- Suspect in any pt w/ ventricular rate >300
Orthodromic Type
- More common type occuring ~95% of the time
- Accessory pathway (Kent bundles) is used for retrograde reentry conduction
- QRS narrow (delta wave absent)
- May see ST depression, TWI
- Rate 150-250 bpm
Antidromic Type
- Least common type occuring ~5% of the time
- Accessory pathway used for anterograde conduction
- QRS wide, delta wave present
Atrial Fibrillation and Flutter
- Atrial fibrillation in up to 20% of pts with WPW
- Atrial flutter in ~7%
- Treatment with AV nodal blocking agents (adenosine, BBs, CCBs, amiodarone) may incite ventricular fibrillation or ventricular tachycardia
Diagnosis
Although the ECG and an electrophysiology study are diagnostic, the characteristic features are not always seen on ECG
- Short PR interval - <0.12sec
- Due to loss of normal AV node conduction delay
- Differentiate from premature junctional complex
- Delta wave / slurred upstroke
- Due to early activation of ventricular myocardium
- QRS duration > 0.10 sec
- Represents a fusion beat
- Dominant R wave in V1, Type A WPW
- Left sided accessory pathway
- Dominant S wave in V1, Type B WPW
- Right sided accessory pathway
- Tall R waves in V1-V3 with T wave inversion
- Mimic RVH
- "Negative" delta waves in III and aVF
- Appear as pseudo-infarct Q waves
- Mimics prior inferior infarct
Treatment
Orthodromic
Treat like paroxysmal SVT'
- Unstable
- Cardioversion (synchronized)
- Adult: 50-100 J
- Peds: 0.5-2 J/kg
- Stable
- CCBs, BBs, procainamide, or adenosine
- Procainamide safe irrespective of type of pathway conduction
Antidromic
Treat like ventricular tachycardia
- Synchronized cardioversion
- Adult: 50-100 J
- Peds: 0.5-2 J/kg
- Procainamide: 17mg/kg IV over 30min (up to 50mg/kg or 50% widening of QRS complex)
- Amiodarone with 'ABCD' drugs ie adenosine, BBs, CCBs, digoxin
- Wide-complex, irregular (presumed preexcited A-fib)
- Unsynchronized cardioversion (200J)
Disposition
- Discharge:
- Consider if dysrhythmia was easily terminated and can arrange outpt EP study with poss RF catheter ablation
- C/w with cardiologist regarding outpt beta-blockers vs. more potent medications (amiodarone, sotalol, flecainide, etc.)
- Admit or transfer to center with electrophys[1]:
- Pts with chest pain, CHF, electrolyte imbalance, or required cardioversion
- Syncope
- Uncertain dx (wide-complex tachycardia)
- Significant associated structural heart disease (MVP, cardiomyopathy)
- Family hx of Sudden cardiac death
- Atrial flutter or atrial fibrillation
See Also
Sources
- Burns E. Pre-excitation Syndromes. Life in the Fast Lane. http://lifeinthefastlane.com/ecg-library/pre-excitation-syndromes/.
- ↑ Ellis CR et al. Wolff-Parkinson-White Syndrome Treatment & Management. eMedicine. Dec 4, 2015. http://emedicine.medscape.com/article/159222-treatment#showall.
